Header cover image

Nigerian (NSE) Pharma Industry Analysis

UpdatedMar 24, 2023
DataAggregated Company Financials
  • 7D0.2%
  • 3M6.1%
  • 1Y14.0%
  • YTD1.7%

In the last week, Pharma has been flat. As for the the longer term, the industry is up 14% over the past 12 months.

Industry Valuation and Performance

Has the Nigerian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 24 Mar 2023₦45.0b₦83.3b₦6.3b5.5x7.1x0.5x
Sun, 19 Feb 2023₦41.8b₦83.3b₦6.3b5.3x6.6x0.5x
Tue, 17 Jan 2023₦40.8b₦83.8b₦7.3b4.8x5.6x0.5x
Thu, 15 Dec 2022₦38.3b₦83.8b₦7.3b4.3x5.2x0.5x
Sat, 12 Nov 2022₦37.7b₦83.8b₦7.3b4.3x5.1x0.4x
Mon, 10 Oct 2022₦36.8b₦81.7b₦7.2b6.6x5.1x0.5x
Wed, 07 Sep 2022₦40.2b₦81.7b₦7.2b7.2x5.6x0.5x
Fri, 05 Aug 2022₦39.4b₦81.7b₦7.2b6.7x5.5x0.5x
Sun, 03 Jul 2022₦41.8b₦76.4b₦6.4b7x6.5x0.5x
Tue, 31 May 2022₦42.8b₦76.3b₦5.8b7.3x7.4x0.6x
Thu, 28 Apr 2022₦34.9b₦67.9b₦4.9b9x7.1x0.5x
Sat, 26 Mar 2022₦35.3b₦67.9b₦4.7b10.5x7.5x0.5x
Mon, 21 Feb 2022₦36.1b₦67.9b₦4.7b10.7x7.7x0.5x
Wed, 19 Jan 2022₦34.2b₦61.7b₦4.9b7x7x0.6x
Fri, 17 Dec 2021₦31.4b₦61.5b₦4.7b6.9x6.7x0.5x
Sun, 14 Nov 2021₦32.7b₦61.5b₦4.7b7.2x6.9x0.5x
Tue, 12 Oct 2021₦32.1b₦55.8b₦3.6b8.2x8.9x0.6x
Thu, 09 Sep 2021₦32.7b₦62.2b₦2.8b8x11.8x0.5x
Sat, 07 Aug 2021₦32.3b₦62.2b₦2.8b8.1x11.6x0.5x
Fri, 30 Apr 2021₦29.9b₦61.7b₦3.0b6.7x10x0.5x
Mon, 01 Feb 2021₦34.3b₦57.9b₦2.1b9.3x16.1x0.6x
Thu, 05 Nov 2020₦26.0b₦56.3b₦2.3b7.9x11.5x0.5x
Sun, 09 Aug 2020₦21.4b₦53.5b₦1.9b6.7x11x0.4x
Sat, 02 May 2020₦18.2b₦52.0b₦1.4b6.8x12.9x0.4x
Price to Earnings Ratio


Total Market Cap: ₦16.1bTotal Earnings: ₦1.4bTotal Revenue: ₦52.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Nigerian Pharma Industry Price to Earnings3Y Average 9.4x202120222023
Current Industry PE
  • Investors are pessimistic on the Nigerien Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 7.1x which is lower than its 3-year average PE of 9.4x.
  • The industry is trading close to its 3-year average PS ratio of 0.49x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 65% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Nigerian Healthcare industry?

NG Market0.0033%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NEIMETH Neimeth International Pharmaceuticals₦1.481.4%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News



Neimeth International Pharmaceuticals